Chemical-structure (Clonidine 01)
Chemical structure of Clonidine, showing a dichlorophenyl ring attached to an imidazoline ring system.*
Clonidine Patch, Extended Release
Product Images NDC 75907-023
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Clonidine (NDC 75907-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr. Reddy's Labratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cross-section (Clonidine 02)
A labeled cross-sectional illustration of a Clonidine transdermal patch showing its layered structure. The layers, from top to bottom, are: backing, drug reservoir, control membrane, adhesive, and slit release liner.*
Figure-1 (Clonidine 03 Figure1)
An instructional illustration showing a transdermal patch applied to the upper arm under a rolled-up sleeve. The image highlights the patch itself and an adhesive cover, which may be applied over the patch if necessary.*
Figure-2-l (Clonidine 04 Figure2 L)
Clonidine Transdermal System USP 0.1 mg/day patch label indicating a one-week delivery of 0.1 mg per day. Label includes MRI safety warning to remove the patch before MRI procedures. Lists active and inactive ingredients and states the product is labeled by Dr. Reddy's Laboratories Inc. The label shows the NDC number and Rx Only status.*
Figure-2-r (Clonidine 05 Figure2 R)
Adhesive cover for Clonidine transdermal patch, extended release. The label states that the cover does not contain active medication and should be applied over the patch if necessary. Instructions for use are referenced in the patient information sheet.*
Figure-3 (Clonidine 06 Figure3)
A black and white instructional illustration showing close-up hands peeling a Clonidine transdermal patch from its protective backing. The patch label visible includes partial text showing the dosage strength in mg/day and mentions the transdermal system. This image visually demonstrates the application step for Clonidine extended-release patches by Dr. Reddy's Laboratories.*
Figure-4 (Clonidine 07 Figure4)
An instructional black-and-white illustration showing a person's hands peeling or applying a rectangular medical patch, likely demonstrating proper handling or application technique.*
Figure-5 (Clonidine 08 Figure5)
A black and white photo showing a person applying a small rectangular transdermal patch to their upper arm, illustrating the topical use of a patch medication. The person wears a short-sleeve argyle-patterned shirt and a ring on their finger.*
Figure-6 (Clonidine 09 Figure6)
Clonidine Transdermal System adhesive cover packaging showing a small square packet labeled with usage instructions and a round, white transdermal patch next to it. The label states the patch does not contain active medication and includes a suggestion to refer to the patient information sheet. The image corresponds to Clonidine patches by Dr. Reddy's Laboratories Inc.*
Principle Display Panel 0.2mg (Clonidine 10 Pdp0.2mg)
Clonidine Transdermal System USP 0.2 mg/day extended release patch packaging label from Dr. Reddy's Laboratories Inc. The label states it delivers 0.2 mg per day for one week and includes 4 systems with 4 adhesive covers. It also warns to remove the patch before MRI procedures and provides inactive ingredients and storage instructions.*
Principle Display Panel 0.1mg (Clonidine 11 Pdp0.1mg)
Clonidine Transdermal System USP 0.1 mg/day extended release patch, programmed for delivery of 0.1 mg per day for one week. The package contains 4 systems and 4 adhesive covers. Labeler is Dr. Reddy's Laboratories, Inc. The label includes storage instructions, inactive ingredients, and a warning to remove the patch before MRI procedures.*
Principle Display Panel 0.3mg (Clonidine 12 Pdp0.3mg)
Clonidine Transdermal System USP 0.3 mg/day extended-release patch packaging label by Dr. Reddy's Laboratories Inc. The label indicates in vivo delivery of 0.3 mg per day for one week and contains 4 systems and 4 adhesive covers. It also includes storage instructions and inactive ingredients details.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
